Masuda, Takahiro
Yoshida, Masahide
Onaka, Tatsushi
Nagata, Daisuke
Article History
Received: 5 January 2024
Revised: 16 August 2024
Accepted: 2 September 2024
First Online: 19 September 2024
Compliance with ethical standards
:
: Astellas Pharma (Tokyo, Japan) provided SGLT2 inhibitor ipragliflozin for this study.